Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A public open day to showcase groundbreaking medical research that is taking place in Oxford across a range of conditions such as cancer and diabetes will be held at the John Radcliffe Hospital (JR) this month.

Talks, a tour of clinical facilities, stalls and a debate about the opportunities and challenges of sharing patient data will feature in the NIHR Oxford Biomedical Research Centre (BRC) Celebrating Biomedical Research Open Day on Thursday, April 21.

The hospital’s Tingewick Hall will be packed with more than 30 stalls, including hands on exhibits, to demonstrate the work of the BRC, a partnership between the University of Oxford and Oxford University Hospitals NHS Foundation Trust (OUH) to fund and support medical research.

The BRC supports research across 14 Themes including cancer, diabetes, genetics, stroke, infection, surgery, vaccines and others.

Attractions will include a new 55-inch touchscreen computer being used to view cells up close for teaching at the JR, a mobile phone app to assess general fitness, a quiz on which foods contain the most iron, a microscope to view blood slides showing acute leukaemia and spectacles that simulate eye diseases.

Doctors and researchers will be on hand to answer questions about their work with the BRC, which has benefited from more than £150m of investment from the National Institute for Health Research (NIHR) since 2007.

The day will begin with a public tour of the University of Oxford’s Acute Vascular Imaging Centre, at the JR. Here, emergency cases who are eligible for study are taken to a MRI scanner during or after treatment in either the hospital’s Cardiac Catheter Labs or the Emergency Department to study the impact of treatments in real time on the body.

Exhibitions, including the Surgical Intervention Trials Unit and the ACST-2 team from the Nuffield Department of Surgical Sciences, will open in Tingewick Hall, in the hospital’s academic block, from midday to 5pm.

At 12.45pm to 1.45pm a debate “Good to share? Data, research, privacy and the NHS” will be held in adjacent Lecture Theatre 2 on the exciting but often challenging issues around mass sharing of patient data to support research and improve patient care.

Audience members will be encouraged to ask questions of panellists, drawn from a spectrum of viewpoints on the issue, which many clinicians believe is vital to making big leaps in our understanding of disease.

Professor Keith Channon, Director of the Oxford BRC and Dr Tony Berendt, Medical Director, OUH will give short keynote speeches at 2pm.

They will be joined by Dr Caroline Hargrove, Technical Director at McLaren Applied Technologies who will talk about how data analysis and simulation tools for motorsport are now driving innovation in surgery and patient care.

Talks by clinicians will then examine some two major healthcare challenges facing research and take questions from the audience.

Professor Adrian Harris, of the University of Oxford Department of Oncology, will talk about “New ways to Treat Cancer” from 3pm to 3.30pm while Dr Matthew Snape, Jenner Investigator and Oxford BRC Consultant in General Paediatrics and Vaccinology, Department of Paediatrics, University of Oxford will speak on “Meningitis Vaccines – can we do more?” from 3.45pm to 4.15pm.

Booking is recommended for all events other than the exhibits at oxfordbrc.nihr.ac.uk or 01865 743341.

Similar stories

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

Varicose veins are a very common manifestation of chronic venous disease, affecting over 30% of the population in Western countries. In America, chronic venous disease affects over 11 million men and 22 million women aged 40–80 years old. Left untreated it can escalate to multiple health complications including leg ulcers and ultimately amputations. A new international study by Oxford researchers published on 2 June 2022 in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Results of the REF 2021: congratulations and thank you

Today, the UK funding bodies have published the results of the UK’s most recent national research assessment exercise, the Research Excellence Framework (REF) 2021.

Blog posts

Oxford MedSci goes silver: 10 Years of Athena SWAN

The Medical Sciences Division is celebrating 10 years since its first Athena Swan bronze application, and the first year in which all 16 of its departments have achieved a silver award. The silver award recognises commitment to gender equality, understanding culture and context, and more. Read about our department’s hard work and innovation.

Lights, camera, action! My journey into video production

Dr Hannah McGivern provides a 'behind-the-scenes' account of her experience producing the video 'Journey of a QUOD Sample: Donating to Transplant Research', supported by the funds from the University of Oxford Public Engagement with Research (PER) Seed Fund.

Mentoring in practice

NDS has launched a new, interdepartmental mentoring scheme called RECOGNISE. In this podcast, Gemma Horbatowski (HR Advisor) interviews Monica Dolton (Programme Manager and Research Project Manager) about her experiences of mentor-mentee relationships.